Skip to main content

Table 2 Guideline recommended care vs. received care

From: Gaps and barriers in health-care provision for co-morbid diabetes and chronic kidney disease: a cross-sectional study

Recommended care Met Unmet P
HbA1c < 8% (64 mmol/mol) when eGFR < 60 mL/min/1.73 m2 [7] 68.1% (192/282) 31.9% (90/282) <0.00001
Blood pressure < 140/90 mmHg [7, 8] 60.7% (187/308) 39.3% (121/308) <0.00001
A statin is recommended in patients with non-dialysis dependent CKD [7] 82.3% (205/249) 17.7% (44/249) <0.00001
In the setting of diabetic retinopathy, eye examinations should be repeated annually by an optometrist/ophthalmologist [20] 87.8% (108/123) 12.2% (15/123) <0.00001
In the setting of peripheral neuropathy feet should be examined every 3 months [20, 37] 49.1% (53/108) 50.9% (55/108) 0.68
Metformin should be ceased if eGFR ≤ 30 ml/min/m2 [7] 96.2% (154/160) 3.8% (6/160) <0.00001
ESAa prescribed if Hb < 100 g/L, allowing for individualisation [19] 50.0% (11/22) 50.0% (11/22) 1.00
Hb between 100 and 115 g/L while on ESA [19] 31.3% (20/64) 68.8% (44/64) <0.00001
  1. aESA = Erythropoietin Stimulating Agent